Day One Biopharmaceuticals
Price & Volume
Stats
See moreOpen | $10.52 |
Previous Close | $10.65 |
Day Range | $10.46-$10.68 |
52W Range | $5.63-$13.20 |
Market Cap | $1.1B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $158.1M |
Revenue Growth (YoY) | 83.9% |
Gross Profit (12 Mos) | $140.9M |
Diluted EPS | -$1.52 |
News
See moreYahoo Finance • 3 days ago
Day One Biopharmaceuticals reports Q4 results
Yahoo Finance • 3 months ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)
Yahoo Finance • 3 months ago
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 3 months ago
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more
About
CEO | Dr. Jeremy Bender M.B.A., Ph.D. |
CFO | Mr. Charles N. York II, M.B.A. |
Address | 1800 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 184 |
